Luisa Schmidt

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Counting the cost of public and philanthropic R&D funding: the case of olaparib.

Counting the cost of public and philanthropic R&D funding: the case of olaparib.

Journal: Journal of pharmaceutical policy and practice
Published: March 06, 2022

EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?

EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?

Journal: Journal of pharmaceutical policy and practice
Published: January 19, 2021

Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.

Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.

Journal: Leukemia
Published: June 19, 2020

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia.

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia.

Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: September 30, 2019

CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

Journal: Blood
Published: September 10, 2019

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

Journal: Life science alliance
Published: October 07, 2018

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.

Journal: Leukemia
Published: August 02, 2018

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.

Journal: Archives of toxicology
Published: July 04, 2016

ATMIN is required for the ATM-mediated signaling and recruitment of 53BP1 to DNA damage sites upon replication stress.

ATMIN is required for the ATM-mediated signaling and recruitment of 53BP1 to DNA damage sites upon replication stress.

Journal: DNA repair
Published: January 29, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026